We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
+2.12%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$971M
AUM Growth
-$19.4M
Cap. Flow
+$172M
Cap. Flow %
17.68%
Top 10 Hldgs %
24.54%
Holding
508
New
199
Increased
44
Reduced
12
Closed
182

Sector Composition

Rank Sector Weight
1 Financials 37.12%
2 Healthcare 13.18%
3 Technology 10.4%
4 Communication Services 6.84%
5 Energy 5.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPHY
226
DELISTED
Epiphany Technology Acquisition Corp. Class A Common Stock
EPHY
$1.07M 0.11%
109,918
+9,918
+10% +$96.7K
IGAC
227
DELISTED
IG Acquisition Corp. Class A Common Stock
IGAC
$1.05M 0.11%
+107,400
New +$1.05M
RMCO icon
228
Royalty Management
RMCO
$35.3M
$1.02M 0.11%
+102,590
New +$1.02M
DAVE icon
229
Dave Inc
DAVE
$5.17B
$989K 0.1%
+3,125
New +$987K
TACA
230
DELISTED
Trepont Acquisition Corp I
TACA
$989K 0.1%
100,000
CAS
231
DELISTED
Cascade Acquisition Corp.
CAS
$988K 0.1%
100,000
FOXW
232
DELISTED
FoxWayne Enterprises Acquisition Corp. Class A Common Stock
FOXW
$985K 0.1%
100,000
LJAQ
233
DELISTED
LightJump Acquisition Corporation Common Stock
LJAQ
$977K 0.1%
100,000
PDOT
234
DELISTED
Peridot Acquisition Corp. II
PDOT
$976K 0.1%
+100,000
New +$976K
HLAH
235
DELISTED
Hamilton Lane Alliance Holdings I, Inc. Class A Common Stock
HLAH
$975K 0.1%
99,999
AONC
236
DELISTED
American Oncology Network, Inc. Class A Common Stock
AONC
$974K 0.1%
+100,000
New +$979K
PMGM
237
DELISTED
Priveterra Acquisition Corp. II Class A Common Stock
PMGM
$972K 0.1%
100,000
SSAA
238
DELISTED
Science Strategic Acquisition Corp. Alpha Class A Common Stock
SSAA
$971K 0.1%
99,999
LDTC
239
DELISTED
LeddarTech
LDTC
$970K 0.1%
200,000
LCAA
240
DELISTED
L Catterton Asia Acquisition Corp Class A Ordinary Shares
LCAA
$970K 0.1%
+99,999
New +$978K
IPVF
241
DELISTED
InterPrivate III Financial Partners Inc.
IPVF
$970K 0.1%
+100,000
New +$974K
HLGN
242
DELISTED
Heliogen, Inc.
HLGN
$970K 0.1%
+2,857
New +$971K
ESM
243
DELISTED
ESM Acquisition Corporation
ESM
$970K 0.1%
+99,999
New +$973K
KLAQ
244
DELISTED
KL Acquisition Corp Class A Common Stock
KLAQ
$970K 0.1%
100,000
GSAQ
245
DELISTED
Global Synergy Acquisition Corp. Class A Ordinary Shares
GSAQ
$970K 0.1%
100,000
AGGR
246
DELISTED
Agile Growth Corp
AGGR
$969K 0.1%
+99,999
New +$975K
SBII
247
DELISTED
Sandbridge X2 Corp.
SBII
$967K 0.1%
+99,999
New +$977K
VPCB
248
DELISTED
VPC Impact Acquisition Holdings II Class A ordinary shre
VPCB
$963K 0.1%
+99,000
New +$971K
TMAC
249
DELISTED
The Music Acquisition Corporation
TMAC
$951K 0.1%
+98,380
New +$962K
IPVI
250
DELISTED
InterPrivate IV InfraTech Partners Inc. Class A Common Stock
IPVI
$950K 0.1%
+97,860
New +$957K

Similar funds

Mangrove Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Mangrove Partners held 508 positions worth $971M, down 2% from $991M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Mangrove Partners deployed $172M of net new capital in Q2 2021, opening 199 new positions and adding to 44 existing holdings. Its largest new stake was Coherent Inc: 74,493 shares worth $19.7M.

By sector, the portfolio is most concentrated in Financials at 37% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was GPGI Inc, an estimated $7.25M trimmed.

  • Mangrove Partners's largest Q2 2021 buy was Coherent Inc: 74,493 shares worth $19.7M.
  • Mangrove Partners added most to Pershing Square Tontine Holdings, Ltd. in Q2 2021, an estimated $32.9M increase.
  • Mangrove Partners's biggest Q2 2021 reduction was GPGI Inc, cutting an estimated $7.25M.
  • Mangrove Partners fully exited Alexion Pharmaceuticals in Q2 2021, selling an estimated $17.3M.
  • Mangrove Partners's ten largest holdings make up 25% of its $971M portfolio in Q2 2021.
  • Mangrove Partners opened 199 new positions and closed 182 in Q2 2021.
  • Mangrove Partners's portfolio value fell 2% quarter-over-quarter to $971M.

Based on Mangrove Partners's 13F filing for Q2 2021, filed 16 Aug 2021.